AZURRX BIOPHARMA : January 2021 Investor Update
MarketScreener,
Annual estimate - currently ~260,000 US incident cancer patients are eligible for treatment with ICI's (44% of patients with…
Annual estimate - currently ~260,000 US incident cancer patients are eligible for treatment with ICI's (44% of patients with…
Despite the clinical benefits of immunotherapy, these treatments are associated with immune-related toxicities that may require…
Immunotherapy, the Nobel Prize-winning category of cancer therapy that helps your immune cells to fight tumors, has transformed…